EHC vs. PFE
EHC (Encompass Health Corporation) and PFE (Pfizer Inc.) are both stocks. Both are in the Healthcare sector — EHC in Medical Care Facilities, PFE in Drug Manufacturers - General. Over the past 5 years, EHC returned 10.23%/yr vs -3.66%/yr for PFE. At a 0.23 correlation, their price movements are largely independent.
Performance
EHC vs. PFE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, EHC achieves a -6.68% return, which is significantly lower than PFE's 4.10% return.
EHC
- 1D
- 0.66%
- 1M
- -5.98%
- YTD
- -6.68%
- 6M
- -7.51%
- 1Y
- -16.65%
- 3Y*
- 15.75%
- 5Y*
- 10.23%
- 10Y*
- —
PFE
- 1D
- -0.52%
- 1M
- -3.17%
- YTD
- 4.10%
- 6M
- 2.82%
- 1Y
- 11.94%
- 3Y*
- -7.59%
- 5Y*
- -3.66%
- 10Y*
- 1.96%
EHC vs. PFE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
EHC Encompass Health Corporation | -6.68% | 15.67% | 39.17% | 12.62% | 16.77% | -19.90% | 21.42% | 14.26% | 26.89% | 0.20% |
PFE Pfizer Inc. | 4.10% | 0.65% | -2.22% | -41.26% | -10.41% | 66.70% | 3.07% | -6.91% | 24.82% | -0.41% |
Correlation
The correlation between EHC and PFE is 0.04, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.04 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.13 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.16 |
Correlation (All Time) Calculated using the full available price history since Dec 29, 2017 | 0.23 |
The correlation between EHC and PFE shifts across timeframes, from 0.04 (1 year) to 0.23 (all time), reflecting how their relationship changes across market environments.
Fundamentals
EHC:
$9.93B
PFE:
$143.73B
EHC:
$5.99
PFE:
$1.31
EHC:
16.49
PFE:
19.11
EHC:
1.38
PFE:
0.34
EHC:
1.66
PFE:
2.26
EHC:
3.00
PFE:
1.60
EHC:
$6.07B
PFE:
$63.32B
EHC:
$2.44B
PFE:
$43.91B
EHC:
$1.42B
PFE:
$16.94B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
EHC vs. PFE — Risk / Return Rank
EHC
PFE
EHC vs. PFE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Encompass Health Corporation (EHC) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| EHC | PFE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.12 | ||
| Sortino ratioReturn per unit of downside risk | -1.67 | ||
| Omega ratioGain probability vs. loss probability | 0.90 | 1.11 | -0.21 |
| Calmar ratioReturn relative to maximum drawdown | -0.64 | 1.05 | -1.69 |
| Martin ratioReturn relative to average drawdown | -1.17 | 2.06 | -3.23 |
Loading charts...
Drawdowns
EHC vs. PFE - Drawdown Comparison
The maximum EHC drawdown since its inception was -39.54%, smaller than the maximum PFE drawdown of -69.24%. Use the drawdown chart below to compare losses from any high point for EHC and PFE.
Loading charts...
Drawdown Indicators
| EHC | PFE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -39.54% | -69.24% | +29.70% |
Max Drawdown (1Y)Largest decline over 1 year | -26.09% | -11.47% | -14.62% |
Max Drawdown (3Y)Largest decline over 3 years | -26.09% | -37.69% | +11.60% |
Max Drawdown (5Y)Largest decline over 5 years | -35.10% | -58.96% | +23.86% |
Max Drawdown (10Y)Largest decline over 10 years | — | -58.96% | — |
Current DrawdownCurrent decline from peak | -22.12% | -48.02% | +25.90% |
Average DrawdownAverage peak-to-trough decline | -12.12% | -22.91% | +10.79% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 14.22% | 5.80% | +8.42% |
Volatility
EHC vs. PFE - Volatility Comparison
Encompass Health Corporation (EHC) has a higher volatility of 8.59% compared to Pfizer Inc. (PFE) at 5.40%. This indicates that EHC's price experiences larger fluctuations and is considered to be riskier than PFE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| EHC | PFE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.59% | 5.40% | +3.19% |
Volatility (6M)Calculated over the trailing 6-month period | 20.86% | 14.21% | +6.65% |
Volatility (1Y)Calculated over the trailing 1-year period | 27.23% | 23.93% | +3.30% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 26.08% | 25.50% | +0.58% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 28.28% | 23.91% | +4.37% |
Dividends
EHC vs. PFE - Dividend Comparison
EHC's dividend yield for the trailing twelve months is around 0.75%, less than PFE's 6.86% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EHC Encompass Health Corporation | 0.75% | 0.66% | 0.51% | 0.90% | 20.45% | 1.72% | 1.35% | 1.59% | 1.69% | 0.51% | 0.00% | 0.00% |
PFE Pfizer Inc. | 6.86% | 6.91% | 6.33% | 5.70% | 3.12% | 2.64% | 3.92% | 3.68% | 3.12% | 3.53% | 3.69% | 3.47% |
Financials
EHC vs. PFE - Financials Comparison
This section allows you to compare key financial metrics between Encompass Health Corporation and Pfizer Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
EHC vs. PFE - Profitability Comparison
EHC - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Encompass Health Corporation reported a gross profit of 768.50M and revenue of 1.59B. Therefore, the gross margin over that period was 48.4%.
PFE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Pfizer Inc. reported a gross profit of 9.72B and revenue of 14.45B. Therefore, the gross margin over that period was 67.3%.
EHC - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Encompass Health Corporation reported an operating income of 232.30M and revenue of 1.59B, resulting in an operating margin of 14.6%.
PFE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Pfizer Inc. reported an operating income of 4.03B and revenue of 14.45B, resulting in an operating margin of 27.9%.
EHC - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Encompass Health Corporation reported a net income of 194.50M and revenue of 1.59B, resulting in a net margin of 12.3%.
PFE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Pfizer Inc. reported a net income of 2.69B and revenue of 14.45B, resulting in a net margin of 18.6%.
Frequently Asked Questions
EHC and PFE have a correlation of 0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
EHC has higher volatility (8.59%) compared to PFE (5.40%). In terms of maximum drawdown, EHC dropped -39.54% vs PFE's -69.24%.
PFE currently has the higher Sharpe Ratio (0.50 vs -0.61), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for EHC and PFE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer